Skip to main content

The Possible Role of Glutathione on the Hepatotoxic Effect of Papaverine Hydrochloride in Vitro

  • Chapter
Biological Reactive Intermediates IV

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 283))

Abstract

Papaverine hydrochloride (papaver) is an isoquinoline alkaloid widely used as a smooth muscle relaxant agent. It is metabolized mainly in the liver by the P-450 system (O-demethylation) to yield several phenolic metabolites (4’-,6-, 7-, 3’-, and 4’,6- demethylated phenols) (Belpaire et al., 1975). Papaver induces hepatotoxicity by an idiosyncratic immune effect (Kiaer et al., 1974) or a direct metabolite-related hepatocellular toxic effect (Acosta et al., 1980; Davila et al., 1989). At the present time, however, there is no direct evidence which suggests that toxic metabolites derived from papaver are responsible for liver cell injury. We had demonstrated previously that a time lag of 6 hr was necessary before papaver injured cultured hepatocytes and that the papaver-phenolic metabolites were considerably less toxic than the parent compound. They were ranked in toxicity as follows: papaver>60H>4’0H>3’OH (Acosta et al., 1980; Davila et al., 1989). According to these results, it seems that the metabolite(s) is (are) not the major cause of liver injury. It is interesting to note, however, that certain principal metabolites of papaver are nearly as toxic as the parent compound, while others clearly represent detoxification pathways; therefore, we can not rule out the possibility that papaver-derived intermediate metabolite(s) is (are) involved in the toxic insult. Some mechanistic alternatives are suggested: 1) papaver itself may be directly responsible for cellular toxicity or be metabolized to toxic products by a pathway not involving O-dealkylation; 2) phenol formation (e.g. at 4’-position) may require an additional O-dealkylation or aromatic hydroxylation to yield a catechol which may undergo oxidation to a reactive ortho-quinone; 3) quinone-methides may be formed following O-dealkylation (Figure 1); and 4) the time lag of 6 hr may represent the time required for bioconversion and accumulation of sufficient quantities of toxic metabolites and/or saturate and deplete intracellular glutathione stores.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Belpaire, F.M., Bogaert, M.G., and Rossel, M.T. (1975). Metabolism of papaverine I. Identification of metabolites in rat liver. Xenobiotica 5, 413–420.

    Article  CAS  PubMed  Google Scholar 

  • Kiaer, H.W., Olsen, S., and Ronnov-Jenssen, V. (1974). Hepatotoxicity of papaverine. Arch. Pathos. 98, 292–296.

    CAS  Google Scholar 

  • Acosta, D., Anuforo, D.C., and Smith, R.V. (1980). Cytotoxicity of acetaminophen and papaverine in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol., 53, 306–314.

    CAS  Google Scholar 

  • Davila, J.C., Hsieh, G.C., Reddy, C.G., Acosta, D., and Davis, P.J. (1989). Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in vitro. The Pharmacologist 31, 179.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Davila, J.C., Acosta, D., Davis, P.J. (1991). The Possible Role of Glutathione on the Hepatotoxic Effect of Papaverine Hydrochloride in Vitro . In: Witmer, C.M., Snyder, R.R., Jollow, D.J., Kalf, G.F., Kocsis, J.J., Sipes, I.G. (eds) Biological Reactive Intermediates IV. Advances in Experimental Medicine and Biology, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5877-0_91

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5877-0_91

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5879-4

  • Online ISBN: 978-1-4684-5877-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics